Total Payments
$2,806
2024 Payments
$980.78
Companies
15
Transactions
102
Medicare Patients
12,289
Medicare Billing
$12.8M
Payment Breakdown by Category
Food & Beverage$2,806 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,806 | 102 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $1,129 | 41 | $0 (2024) |
| Genentech USA, Inc. | $321.71 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $232.50 | 7 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $181.27 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $160.75 | 2 | $0 (2024) |
| Alimera Sciences, Inc. | $153.01 | 4 | $0 (2024) |
| Allergan Inc. | $135.00 | 7 | $0 (2019) |
| ABBVIE INC. | $132.95 | 5 | $0 (2024) |
| EKOS Corporation | $110.62 | 1 | $0 (2017) |
| Biogen, Inc. | $95.31 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.78 | 31 | Regeneron Healthcare Solutions, Inc. ($324.00) |
| 2023 | $585.48 | 22 | Regeneron Healthcare Solutions, Inc. ($291.23) |
| 2022 | $402.86 | 12 | Regeneron Healthcare Solutions, Inc. ($261.12) |
| 2021 | $181.78 | 7 | Regeneron Healthcare Solutions, Inc. ($156.83) |
| 2020 | $92.52 | 4 | Regeneron Healthcare Solutions, Inc. ($67.98) |
| 2019 | $64.70 | 4 | Allergan Inc. ($36.32) |
| 2018 | $243.58 | 15 | Genentech USA, Inc. ($118.55) |
| 2017 | $254.05 | 7 | EKOS Corporation ($110.62) |
All Payment Transactions
102 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.04 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.00 | General |
| Category: Ophthalmology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $35.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/21/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Ophthalmology | ||||||
| 10/14/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.94 | General |
| Category: Ophthalmology | ||||||
| 09/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $6.17 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $34.33 | General |
| Category: Ophthalmology | ||||||
| 07/25/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/22/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Ophthalmology | ||||||
| 07/01/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $33.01 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.85 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/31/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: EYE CARE | ||||||
| 05/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/14/2024 | Biogen, Inc. | BYOOVIZ (Biological) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: Ophthalmology | ||||||
| 05/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.43 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/06/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.75 | General |
| Category: Ophthalmology | ||||||
| 04/15/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Ophthalmology | ||||||
| 03/22/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $39.72 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 3,084 | 17,877 | $12.0M | $3.0M |
| 2022 | 13 | 3,107 | 11,033 | $7.4M | $2.9M |
| 2021 | 12 | 3,077 | 14,140 | $8.0M | $3.3M |
| 2020 | 10 | 3,021 | 15,277 | $8.6M | $3.6M |
Total Patients
12,289
Total Services
58,327
Medicare Billing
$12.8M
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 253 | 2,228 | $6.0M | $1.5M | 25.6% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 75 | 1,130 | $949,200 | $245,834 | 25.9% |
| J3590 | Unclassified biologics | Office | 2023 | 53 | 116 | $856,813 | $224,413 | 26.2% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 23 | 7,262 | $820,801 | $210,140 | 25.6% |
| J3490 | Unclassified drugs | Office | 2023 | 37 | 92 | $669,933 | $169,973 | 25.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 413 | 1,450 | $663,920 | $143,893 | 21.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 746 | 1,386 | $548,856 | $123,356 | 22.5% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 32 | 945 | $426,195 | $113,741 | 26.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 52 | 572 | $443,300 | $102,455 | 23.1% |
| 92134 | Imaging of retina | Office | 2023 | 913 | 2,192 | $278,384 | $65,887 | 23.7% |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | Facility | 2023 | 13 | 14 | $55,158 | $12,717 | 23.1% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 117 | 117 | $54,873 | $12,093 | 22.0% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $40,139 | $10,090 | 25.1% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 80 | 82 | $32,308 | $8,404 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 77 | $30,800 | $7,990 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $25,529 | $6,245 | 24.5% |
| 92250 | Photography of the retina | Office | 2023 | 99 | 100 | $11,600 | $2,607 | 22.5% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 34 | 34 | $9,520 | $2,408 | 25.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 15 | 20 | $7,110 | $1,492 | 21.0% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 289 | 2,748 | $4.2M | $2.0M | 46.5% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 185 | 2,461 | $1.5M | $569,153 | 38.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 419 | 1,544 | $833,530 | $150,327 | 18.0% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 771 | 1,451 | $315,524 | $129,886 | 41.2% |
| 92134 | Imaging of retina | Office | 2022 | 916 | 2,262 | $333,306 | $67,788 | 20.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 119 | 122 | $35,432 | $11,722 | 33.1% |
About Dr. Eric Chen, MD
Dr. Eric Chen, MD is a Ophthalmology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578521779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Chen, MD has received a total of $2,806 in payments from pharmaceutical and medical device companies, with $980.78 received in 2024. These payments were reported across 102 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,806).
As a Medicare-enrolled provider, Chen has provided services to 12,289 Medicare beneficiaries, totaling 58,327 services with total Medicare billing of $12.8M. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Houston, TX
- Active Since 05/04/2006
- Last Updated 03/29/2017
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1578521779
Products in Payments
- EYLEA (Biological) $679.13
- EYLEA HD (Biological) $422.03
- OZURDEX (Drug) $267.95
- Syfovre (Drug) $181.27
- Lucentis (Biological) $173.36
- Izervay (Drug) $168.06
- SPRAVATO (Drug) $149.99
- Vabysmo (Drug) $148.35
- EKOSONIC (Device) $110.62
- ILUVIEN (Drug) $97.43
- Implantable Miniature Telescope (Device) $70.11
- YUTIQ (Drug) $44.21
- BYOOVIZ (Biological) $29.62
- EYLEA AFLIBERCEPT INJECTION (Biological) $27.74
- TIBSOVO (Drug) $24.95
- AcrySof IQ PanOptix (Device) $24.54
- VISUDYNE (Drug) $24.39
- Iluvien (Drug) $11.37
- INVEGA SUSTENNA (Drug) $10.76
- (820) Cholbam (Drug) $9.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Houston
Stephen Slade, M.d, M.D
Ophthalmology — Payments: $1.5M
Ophthalmology $1.5M
Dr. Christina Weng, M.d., M.b.a, M.D., M.B.A
Ophthalmology — Payments: $635,330
Ophthalmology $635,330
Zaina Al-Mohtaseb, Md, MD
Ophthalmology — Payments: $559,665
Ophthalmology $559,665
Dr. John Micheletti, M.d, M.D
Ophthalmology — Payments: $555,738
Ophthalmology $555,738
David Brown, M.d, M.D
Ophthalmology — Payments: $488,095
Ophthalmology $488,095
Dr. Douglas Koch, M.d, M.D
Ophthalmology — Payments: $457,260
Ophthalmology $457,260